IGF2BP3 regulates the cell cycle and angiogenesis by targeting CCND1 mRNA and VEGF mRNA via reading m6A modifications, thus promoting tumor growth in vivo [78]. This evidence concerns the gene IGF2BP3 and neoplasm.